'Crazy Monkey' poisons man and dog: Human and canine seizures due to PB-22, a novel synthetic cannabinoid

Clinical Toxicology

Volumn 52, Issue 6, 2014, Pages 635-638

  Gugelmann, H ^a,b   Gerona, R ^c   Li, C ^d   Tsutaoka, B ^a   Olson, K R ^a   Lung, D ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d San Francisco Society for the Prevention of Cruelty to Animals   (United States)

Author keywords

Drug analog act; K2; Legal high; Spice; Synthetic cannabinoid

Indexed keywords

1 PENTYL 1H INDOLE 3 CARBOXYLIC ACID 8 QUINOLINYL ESTER; BENZODIAZEPINE DERIVATIVE; CANNABINOID DERIVATIVE; CARBON DIOXIDE; ETOMIDATE; GLUCOSE; LACTIC ACID; MIDAZOLAM; ONDANSETRON; POTASSIUM; PROPOFOL; ROCURONIUM; SODIUM ION; UNCLASSIFIED DRUG;

ADULT; AGITATION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY TEMPERATURE; BREATHING RATE; CARBON DIOXIDE TENSION; CASE REPORT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONFUSION; ELECTROCARDIOGRAM; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; ENDOTRACHEAL INTUBATION; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; GLASGOW COMA SCALE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYDRATION; HYPERESTHESIA; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; LEUKOCYTE COUNT; MALE; NAUSEA AND VOMITING; NEUROLOGIC EXAMINATION; NEUROTOXICITY; NONHUMAN; PARALYSIS; POTASSIUM BLOOD LEVEL; PULSE RATE; QRS COMPLEX; QT INTERVAL; SEDATION; SINUS RHYTHM; SMOKING; SODIUM BLOOD LEVEL; TIME OF FLIGHT MASS SPECTROMETRY; TONIC CLONIC SEIZURE; UREA NITROGEN BLOOD LEVEL; URINALYSIS; URINE INCONTINENCE; YOUNG ADULT;

DRUG ANALOG ACT; K2; LEGAL HIGH; SPICE; SYNTHETIC CANNABINOID;

ANIMALS; CANNABINOIDS; DOG DISEASES; DOGS; HUMANS; INDOLES; MALE; QUINOLINES; SEIZURES; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84903155402     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2014.925562     Document Type: Article

References (17)

1. European Monitoring Centre for Drugs and Drug Addiction EMCDDA 2009 Thematic paper-Understanding the ' Spice ' phenomenon Luxembourg: Office for Official Publications of the European Communities 2009. ISBN 978-92-9168-411-3. Available at: Http://www. emcdda.europa.eu/attachements.cfm/att-80086-EN-EMCDDA- Understanding%20the%20%E2%80%98Spice%E2%80%99%20 phenomenon-4Update%2020090813. pdf. Accessed May 7th, 2014.
2. Alhadi S, Tiwari A, Vohra R, Gerona R, Acharya J, Bilello K. High times, low sats: Diffuse pulmonary infi ltrates associated with chronic synthetic cannabinoid use. J Med Toxicol 2013; 9: 199-206.
3. Centers for Disease Control and Prevention (CDC). Acute kidney injury associated with synthetic cannabinoid use-multiple states, 2012. MMWR Morb Mortal Wkly Rep 2013; 62: 93-98. Available at: Http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm6206a1.htm. Accessed May 7th, 2014
4. Bebarta VS, Ramirez S, Varney SM. Complication of spice use in a deployed combat setting-seizure while on duty. Am J Addict 2012; 21: 496-497.
5. Loschner A, Cihla A, Jalali F, Ghamande S. Diffuse Alveolar Hemorrhage: Add " Greenhouse Effect " to the growing list. Chest 2011; 140: 149A-149A. Available at: Http://www.journal.publications.chestnet. org/article.aspx?articleID-1088295. Accessed May 7th, 2014.
6. Bernson-Leung ME, Leung L, Kumar S. Synthetic cannabis and acute ischemic stroke. J Stroke Cerebrovasc Dis Available online 8 October 2013, ISSN 1052-3057, http://www.dx.doi.org/10.1016/j.jstrokecereb rovasdis.2013.07.030. Accessed May 7th, 2014.
7. Begg M, Pacher P, Btkai S, Osei-Hyiaman D, Offertler L, Mo FM, et al. Evidence for novel cannabinoid receptors. Pharmacol Ther 2005; 106: 133-145.
8. Huestis MA, Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Frank RA. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiatry 2001; 58: 322-328. (Pubitemid 32299527)
9. Uchiyama N, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y. Two new-Type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and fi ve synthetic cannabinoids detected with a thiophene derivative a-PVT and an opioid receptor agonist AH-7921 identifi ed in illegal products. Forensic Toxicol 2013; 31: 223-240.
10. Fitzgerald KT, Bronstein AC, Newquist KL. Marijuana poisoning. Top Companion Anim Med 2013; 28: 8-12.
11. Centers for Disease Control and Prevention (CDC). Notes from the fi eld: Severe illness associated with synthetic cannabinoid use-Brunswick, Georgia, 2013. MMWR Morb Mortal Wkly Rep 2013; 62: 939.
12. Monte AA, Bronstein AC, Cao DJ, Heard KJ, Hoppe JA, Hoyte CO, et al. An outbreak of exposure to a novel synthetic cannabinoid. N Engl J Med 2014; 370: 389-390.
13. Pant S, Deshmukh A, Dholaria B, Kaur V, Ramavaram S, Ukor M, Teran GA. Spicy seizure. Am J Med Sci 2012; 344: 67-68.
14. M cQuade D, H udson S, D argan P I, W ood D. F irst European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201. Eur J Clin Pharmacol 2013; 69: 373-376.
15. EkaJ (20 February 2011). " The night i killed my friends". Erowid.org. Available at: Http://www.erowid.org/experiences/exp.php?ID-89294. Accessed May 7th, 2014.
16. Schneir AB, Baumbacher T. Convulsions associated with the use of a synthetic cannabinoid product. J Med Toxicol 2012; 8: 62-64.
17. Wallace MJ, Blair RE, Falenski KW, Martin BR, DeLorenzo RJ. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J Pharmacol Exp Ther 2003; 307: 129-137. (Pubitemid 37151898)